MedPath

A comparison of the efficacy of combined intramuscular Pentazocine and Diclofenac versus Bupivacaine Infiltration and intramuscular Diclofenac, for post Caesarean analgesia in Federal Medical Centre, Gusau: A Randomized Controlled Trial.

Phase 1
Conditions
Caesarean section
Registration Number
PACTR202312806863861
Lead Sponsor
PRIMARY RESEARCHER
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
170
Inclusion Criteria

Pregnant women planned for elective caesarean section under spinal anaesthesia regardless of number of previous caesarean sections who consents to participate in the study after proper and appropriate counselling.

Exclusion Criteria

1.Patients that are not able to understand or to use VAS(mentally retarded, psychiatric disorder)
2.Patient that undergoes caesarean section under general anaesthesia
3.Patients with proven or suspected allergy to local anaesthetics
4.Patients with proven or suspected allergy to Pentazocine or Diclofenac.
5.Patients chronically (more than 2 weeks) treated with Opioids medications.
6.Patients that are Opioids dependent or addicted ( determine by their previous experience with Opioids)
7.Patient with sickle cell disease or with uncontrollable diabetic mellitus.
8.Patients with chronic medical condition such as cardiovascular, hepatic or renal insufficiency
9.Booked pregnant women that did not consent
10.All emergencies or complicated caesarean sections such as obstructed labour, foetal distress, prolonged labour etc.
11.Patients with Intrauterine foetal death or Major foetal malformation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath